Evidence map›Paper›PMID 28243799›Full record

ArticleRheumatology international2017

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.

Irene Llorente, Leticia Merino, Ana M Ortiz, Eugenio Escolano, Saturnino González-Ortega, Rosario García-Vicuña, Jesús A García-Vadillo, Santos Castañeda, Isidoro González-Álvaro

Open access · hybridAbstract read
In one paragraph

Article in Rheumatology international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Autoantibodies Serum Level and 10-Year Risk of Fractures Evaluated by FRAXOpen access rheumatology : research and reviews · 2024
    Article
  9. Article
  10. Article
  11. Secondary Osteoporosis and Metabolic Bone Diseases.Journal of clinical medicine · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Irene LlorenteRheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, C/ Diego de León 62, 28006, Madrid, Spain.
Leticia MerinoRheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, C/ Diego de León 62, 28006, Madrid, Spain.
Ana M OrtizRheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, C/ Diego de León 62, 28006, Madrid, Spain.
Eugenio EscolanoRadiology Department, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain.
Saturnino González-OrtegaRadiology Department, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain.
Rosario García-VicuñaRheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, C/ Diego de León 62, 28006, Madrid, Spain.
Jesús A García-VadilloRheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, C/ Diego de León 62, 28006, Madrid, Spain.
Santos CastañedaRheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, C/ Diego de León 62, 28006, Madrid, Spain. scastas@gmail.com.
Isidoro González-ÁlvaroRheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, C/ Diego de León 62, 28006, Madrid, Spain. isidoro.ga@ser.es.
Hospital Universitario de La Princesa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the previous studies showed that anti-citrullinated protein antibodies (ACPA) can induce osteoclasts differentiation and activation, even before arthritis onset, the aim of our study was to determine whether ACPA-positivity is associated with lower bone mineral density (BMD) at baseline visit of a register of early arthritis (EA) patients. The study population comprised 578 patients (80% females) from our EA clinic with a median disease duration, 5.1 months (p25-p75: 6-8); median age, 53.6 years (41.9-66.1), 38% ACPA-positive, and 55% fulfilling 2010 criteria for rheumatoid arthritis. BMD was measured using dual X-ray absorptiometry at lumbar spine, hip, and metacarpophalangeal (MCP) joints of the non-dominant hand to evaluate both systemic and juxta-articular bone mass. ACPA titers were determined through enzyme immunoassay. The effect of ACPA on BMD was analyzed using multivariable analysis based on generalized linear models adjusted for various confounders. ACPA-positive patients showed lower bone mass at lumbar spine and hip, but no differences were observed at MCP joints compared to ACPA-negative patients. However, ACPA-positive patients displayed higher disease activity and disability than ACPA-negative patients. After adjustment for gender, age, body mass index, and other bone-related variables, the presence of ACPA remained significantly associated with lower BMD at the lumbar spine, femoral neck, and hip but not at MCP joints. Disease activity was not associated with baseline bone mass. Our data reinforce the previous preclinical findings suggesting that the systemic bone loss detected at the initial phases of early ACPA-positive arthritis is independent of inflammatory status and, therefore, could be mediated by ACPA.

Indexed as

Absorptiometry, PhotonAdultAgedArthritis, RheumatoidAutoantibodiesBone DensityHip JointHumansLumbar VertebraeMetacarpophalangeal JointMiddle AgedPeptides, CyclicRegistriesAutoantibodiescyclic citrullinated peptidePeptides, CyclicAutoantibodiesAutoimmunityBone mineral densityRheumatoid arthritis

Identifiers

PMID28243799
PMCPMC5397447
OpenAlexW2594281572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.